Drug Profile
Research programme: Hedgehog pathway inhibitors - Curis/Genentech
Alternative Names: Hedgehog signalling pathway inhibitors - Curis/Genentech; Hh antagonists – Curis/Genentech; HhAntagLatest Information Update: 23 Mar 2012
Price :
$50
*
At a glance
- Originator Curis
- Developer Curis; Genentech
- Class Antibodies; Dioxoles; Piperazines; Small molecules
- Mechanism of Action Hedgehog cell-signalling pathway inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Brain cancer; Pancreatic cancer; Solid tumours
Most Recent Events
- 23 Mar 2012 No development reported - Preclinical for Brain cancer in USA (PO)
- 23 Mar 2012 No development reported - Preclinical for Pancreatic cancer in USA (unspecified route)
- 23 Mar 2012 No development reported - Preclinical for Solid tumours in USA (IV)